Swiss National Bank Has $19 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

Swiss National Bank decreased its position in shares of Encompass Health Co. (NYSE:EHC) by 0.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 196,600 shares of the company’s stock after selling 400 shares during the period. Swiss National Bank owned 0.20% of Encompass Health worth $18,999,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Thrivent Financial for Lutherans grew its stake in shares of Encompass Health by 26.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after buying an additional 156,938 shares in the last quarter. Natixis Advisors LLC grew its position in Encompass Health by 7.8% in the third quarter. Natixis Advisors LLC now owns 101,296 shares of the company’s stock worth $9,789,000 after acquiring an additional 7,294 shares in the last quarter. CIBC Asset Management Inc increased its stake in shares of Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after purchasing an additional 100 shares during the last quarter. OneDigital Investment Advisors LLC bought a new position in shares of Encompass Health during the 3rd quarter valued at $207,000. Finally, KBC Group NV lifted its stake in shares of Encompass Health by 11.3% in the 3rd quarter. KBC Group NV now owns 2,757 shares of the company’s stock valued at $266,000 after purchasing an additional 279 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on EHC shares. UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Stephens restated an “overweight” rating and issued a $105.00 target price on shares of Encompass Health in a report on Tuesday, August 6th. Barclays increased their price target on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Truist Financial restated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Performance

NYSE EHC opened at $98.98 on Friday. The company’s fifty day moving average is $96.96 and its two-hundred day moving average is $90.69. The firm has a market capitalization of $9.97 billion, a price-to-earnings ratio of 23.91, a P/E/G ratio of 1.31 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a 52-week low of $63.78 and a 52-week high of $104.55.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period last year, the business earned $0.86 earnings per share. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. Equities research analysts forecast that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s dividend payout ratio (DPR) is currently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.